Seminars in Oncology
Volume 34, Supplement 1 , Pages S2-S6, April 2007

Molecular Mechanisms in Barrett’s Metaplasia and Its Progression

  • Julie G. Izzo

      Affiliations

    • Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
    • Corresponding Author InformationAddress reprint requests to Julie G. Izzo, MD, Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit #19, Houston, TX 77030-4009.
    • ,
  • Rajyalakshmi Luthra

      Affiliations

    • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
    • ,
  • Tseung-Teh Wu

      Affiliations

    • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
    • ,
  • Arlene M. Correa

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
    • ,
  • Madan Luthra

      Affiliations

    • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
    • ,
  • Sharmila Anandasabapathy

      Affiliations

    • Department of Gastrointestinal Medicine and Nutrition, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
    • ,
  • K.S. Clifford Chao

      Affiliations

    • Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
    • ,
  • Mien-Chie Hung

      Affiliations

    • Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
    • ,
  • Bharat Aggarwal

      Affiliations

    • Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
    • ,
  • Walter N. Hittelman

      Affiliations

    • Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
    • ,
  • Jaffer A. Ajani

      Affiliations

    • Department of Gastrointestinal Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by National Institutes of Health grant nos. NIH-NCI RO1 DE13157-04 (to W.N.H.), NIH-NCI EDRN CA 86390 (to M.R.S.), and the University of Texas M. D. Anderson Esophageal Multidisciplinary Research Project Grant, Riverkreek Foundation, and the Dallas, Cantu, Smith, and Park Families.

PII: S0093-7754(07)00022-X

doi:10.1053/j.seminoncol.2007.01.005

Seminars in Oncology
Volume 34, Supplement 1 , Pages S2-S6, April 2007

Article Tools

* Image Usage & Resolution